What is Ipilimumab?

Category: Prescription Drugs

Most popular types: Yervoy

false

Ipilimumab is a monoclonal antibody used for the treatment of unresectable or metastatic melanoma.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 1
Moderate 1
Mild 1
None 0

Commonly reported side effects and conditions associated with Ipilimumab

Side effect Patients
Elevated liver enzymes 1
Fever/chills 1
Hypothyroidism 1
Itchy rash 1
Pancreatitis 1
Ulcerative colitis 1

Dosages

Based on patients currently taking Ipilimumab

Dosage Patients
5 mg every 3 weeks 1
200 mg every 3 weeks 1

Why patients stopped taking Ipilimumab

Multiple reasons could be selected

Reason Patients
Side effects too severe 3
Course of treatment ended 2
Doctor's advice 1
See all 5 patients who've stopped taking Ipilimumab

Duration

Currently taking Ipilimumab

Duration Patients
1 - 6 months 1
1 - 2 years 1

Stopped taking Ipilimumab

Duration Patients
Less than 1 month 3
1 - 6 months 2
Adherence
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0

What people switch to and from

Patients started taking Ipilimumab after stopping:

Treatment Patients
Pembrolizumab (Keytruda) 2
Bevacizumab (Avastin) 1
Capecitabine (Xeloda) 1
Nivolumab (Opdivo) 1
Oxaliplatin 1

Patients stopped taking Ipilimumab and switched to:

Treatment Patients
Pembrolizumab (Keytruda) 1
Trametinib (Mekinist) 1
Last updated:
There are no evaluations for Ipilimumab.